Centrica PLC
Publication of Prospectus
The following Supplemental Prospectus has been approved by the UK Listing
Authority and is available for viewing:
Supplemental Prospectus dated 12 April 2006 relating to the U.S.$2,000,000,000
Euro Medium Term Note Programme of Centrica plc (the 'Supplemental Prospectus').
To view the full document, please paste the URL into the address bar of your
browser.
Supplemental Prospectus:
http://www.fsa.gov.uk/ukla/
For further information, please contact:
Centrica Media Relations 01753 494085
Centrica Investor Relations 01753 494900
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplemental Prospectus may be
addressed to and/or targeted at persons who are residents of particular
countries (specified in the Supplemental Prospectus) only and is not intended
for use and should not be relied upon by any person outside these countries
and/or to whom the offer contained in the Supplemental Prospectus is not
addressed. Prior to relying on the information contained in the Supplemental
Prospectus, you must ascertain from the Supplemental Prospectus whether or not
you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above
requirement
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.